In this dataset, we provide mechanistic insights into novel type 1 1/2 inhibitors developed by Walter et al., (2017) using: Combi-QSAR, E-pharmacophore modeling, Molecular docking, and Quantum mechanics (HOMO, LUMO, and MESP) methods. Finally, we generated 592 unique lead compounds using Bioisostere replacement methods. 474 were within the applicability domain (AD) of our QSAR model. The biological activities (pIC50) of the compounds (474) were predicted using our QSAR model and the binding free energy of the top compounds (pIC50 > 3.0) was calculated by docking.